China Health Industries Holdings IncOTCQB:CHHE
- LAST PRICE1.2500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 1.2500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
China Health Industries Holdings Inc | 81.9M | -609.8x | --- |
Jasper Therapeutics Inc | 69.7M | -0.7x | --- |
ASP Isotopes Inc | 94.1M | -4.5x | --- |
Global Pharmatech Inc | 79.0M | -2.1x | --- |
Eyenovia Inc | 63.1M | -2.1x | --- |
Spectral Medical Inc | 77.0M | -13.0x | --- |
Company Information
China Health Industries Holdings, Inc. is a manufacturer of health food products. The Company's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The Company has three operating segments: Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is engaged in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas, and oral liquids. As of June 30, 2016, the Company, through Humankind manufactured and sold 14 health supplement products. As of June 30, 2016, the Company, through HLJ Huimeijia manufactured and sold 21 products. The Company's products are sold through sales agents.
Contact Information
- Headquarters
- Songbei District, 168 Binbei StreetHAERBIN, HNG, China 150000
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Treasurer
- Xin Sun
- President, Secretary, Director
- Baosen Ma
- Director
- Kai Sun
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $81.9M |
|---|---|
Revenue (TTM) | $149.9K |
Shares Outstanding | 65.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.60 |
P/E Ratio | -609.8x |
Price/Sales (TTM) | 546.6 |
Price/Cash Flow (TTM) | 167.0x |
Operating Margin | -1,024.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
